Segment Information (Notes)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

24. Segment Information

Information regarding the Company’s segments for the year ended December 31, 2018 and 2017 is as follows:

Revenues by segment	Year Ended December 31,
(in thousands)	2018		2017
Pharmaceutical	$	80,796	$	69,032
Medical Devices	24,652		15,091
Income Generating Assets	92,662		235,937
Total revenues	$	198,110	$	320,060

(Loss) income by segment	Year Ended December 31,
(in thousands)	2018			2017
Pharmaceutical	$	(98,368	)	$	(5,755	)
Medical Devices	(5,086		)	(9,256		)
Income Generating Assets	34,595			125,759
Total net (loss) income	$	(68,859	)	$	110,748

Long-lived assets by segment	Year Ended December 31,
(in thousands)	2018		2017
Pharmaceutical	$	3,682	$	822
Medical Devices	3,545		6,263
Income Generating Assets	160		137
Total long-lived assets	$	7,387	$	7,222

The operations for the Company’s Pharmaceutical and Medical Devices segments are primarily located in Ireland and the United States, respectively.